A 67-year-old woman with a residual tumor of postoperative nonfunctioning pituitary adenoma was suffering from appetite loss and consciousness disorder. She had been treated with hydrocortisone, levothyroxine and desmopressin for complicated hypopituitarism and central diabetes insipidus; however, the treatment was transiently ceased due to
Intern Med 59: 869-870, 2020 DOI: 10.2169/internalmedicine.3678-19 consciousness loss. Since laboratory tests revealed extremely high serum sodium levels (184 mmol/L), administration of desmopressin was resumed, and her sodium level gradually normalized. Computed tomography revealed an apoplexic pituitary mass (Picture, arrow), while magnetic resonance imaging revealed hyperintense lesions in the pons (Picture, arrowheads) on fluid-attenuated inversion recovery and diffusion-weighted imaging, indicating osmotic demyelination syndrome (ODS). ODS is generally caused by rapidly corrected hyponatremia, leading to vascular endothelial damage with blood-brain barrier breakage (1) . Hypernatremia triggered by cessation of desmopressin after apoplexy (2) might have been involved in the occurrence of ODS with prolonged consciousness loss. The possibility of ODS should be considered when encountering a patient with rap-idly progressive hypernatremia who has developed consciousness disorder.
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